The Association Between Completion of Supervised Exercise Therapy and Long-Term Outcomes in Patients with Intermittent Claudication, Concomitant Sarcopenia, and Cardiometabolic Multimorbidity
Annals of Vascular Surgery · 2025
DOI: 10.1016/j.avsg.2024.04.032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Vascular Surgery, 2025. Verfasst von Bharadhwaj Ravindhran und 9 weiteren Autor:innen. Beteiligte Einrichtung: Academic Vascular Surgical Unit, 2nd Floor, Allam diabetes centre, Hull Royal Infirmary, Hull, UK. Electronic address: Bharadhwaj.ravindhran@nhs.net. Hauptthemen laut MEDLINE: Sarcopenia, Intermittent Claudication, Multimorbidity, Exercise Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: The combination of intermittent claudication (IC), cardiometabolic multimorbidity (CMM), and sarcopenia is associated with worse outcomes than IC alone. This study aimed to identify whether the completion of supervised exercise therapy (SET) attenuates these adverse outcomes in patients with combined IC, sarcopenia, and CMM. METHODS: This registry review included consecutive IC patients with concomitant CMM and sarcopenia, who were referred for SET from 2014 to 2017. CMM was defined as 2 or more comorbidities (diabetes, heart disease, stroke, or chronic kidney disease). Sarcopenia was assessed using the L3-skeletal muscle index (L3SMI) from computed tomography (CT) scans in the preceding 18 months. The outcomes of interest were progression to chronic limb-threatening ischemia (CLTI), major adverse cardiovascular events (MACE), and major adverse limb events (MALE). Survival and Cox regression analyses were performed. RESULTS: Eighty-two patients with a combination of IC, CMM, and sarcopenia were included. Of these, 56 declined or prematurely discontinued SET and 26 completed SET. Baseline characteristics and L3SMI did not significantly differ between groups. Completion of SET was associated with slower progression to CLTI (HR: 0.23; 95% CI: 0.07-0.69; P = 0.02) and a reduced risk of MALE (HR: 0.21; 95% CI: 0.057-0.775; P = 0.02). However, there was no reduction in the risk of MACE (HR: 0.88; 95%CI: 0.423-1.629; P = 0.73). Models demonstrated good predictive accuracy (Harrell's C-index >0.6). CONCLUSIONS: Completion of SET was associated with significant improvements in adverse limb outcomes in patients with IC, concomitant sarcopenia, and CMM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Academic Vascular Surgical Unit, 2nd Floor, Allam diabetes centre, Hull Royal Infirmary, Hull, UK. Electronic address: Bharadhwaj.ravindhran@nhs.net.
- Academic Vascular Surgical Unit, 2nd Floor, Allam diabetes centre, Hull Royal Infirmary, Hull, UK.
- Academic Vascular Surgical Unit, 2nd Floor, Allam diabetes centre, Hull Royal Infirmary, Hull, UK; Department of Sport and Exercise Sciences, Institute of Sport, Manchester Metropolitan University, Hull, UK.
Zitieren
APA
Ravindhran, B., Igwe, C., Prosser, J., Nazir, S., Harwood, A. E., Lathan, R., Carradice, D., Smith, G. E., Chetter, I. C., & Pymer, S. (2025). The Association Between Completion of Supervised Exercise Therapy and Long-Term Outcomes in Patients with Intermittent Claudication, Concomitant Sarcopenia, and Cardiometabolic Multimorbidity. Annals of Vascular Surgery. https://doi.org/10.1016/j.avsg.2024.04.032
Vancouver
Ravindhran B, Igwe C, Prosser J, Nazir S, Harwood AE, Lathan R, et al. The Association Between Completion of Supervised Exercise Therapy and Long-Term Outcomes in Patients with Intermittent Claudication, Concomitant Sarcopenia, and Cardiometabolic Multimorbidity. Annals of Vascular Surgery. 2025. doi:10.1016/j.avsg.2024.04.032
BibTeX
@article{Ravindhran2025,
author = {Ravindhran, Bharadhwaj and Igwe, Chukwuemeka and Prosser, Jonathan and Nazir, Shahani and Harwood, Amy E and Lathan, Ross and Carradice, Daniel and Smith, George E and Chetter, Ian C and Pymer, Sean},
title = {The Association Between Completion of Supervised Exercise Therapy and Long-Term Outcomes in Patients with Intermittent Claudication, Concomitant Sarcopenia, and Cardiometabolic Multimorbidity},
journal = {Annals of Vascular Surgery},
year = {2025},
doi = {10.1016/j.avsg.2024.04.032}
}
EUVIMED